RecruitingNCT02495337

Tissue Collection Protocol for Gastroesophageal Cancers

Tissue Collection for Gastro-esophageal Cancer Primary Cell Line Establishment


Sponsor

University Health Network, Toronto

Enrollment

100 participants

Start Date

May 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

This proposed collection of primary tumor cells lines will benefit esophageal cancer research within the University Health Network. This collection of gastro-esophageal tumor samples will be used to grow primary tumor cell lines, which will provide researchers with ready samples of various gastro-esophageal cancers. This will help to address the issue of access to these cell lines due to the limited number of patients with gastro-esophageal tumors, and high rates of contamination.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects tissue samples from patients with cancers of the esophagus or stomach, or conditions like GERD (acid reflux) or Barrett's esophagus, to help researchers better understand and treat these diseases. **You may be eligible if...** - You have esophageal or stomach cancer, acid reflux (GERD), or Barrett's esophagus - You are already scheduled to have surgery or an endoscopy (a procedure where a camera is used to look inside your digestive tract) as part of your standard medical care **You may NOT be eligible if...** - You are not healthy enough to undergo surgery or an endoscopy as part of your standard care Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTissue Collection

Locations(1)

University Health Network: Toronto General Hospital

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02495337


Related Trials